Tumor cells of the carcinomatous component showed positive immunostaining for WT1, for EMA and for estrogen receptor (80%) and progesterone receptor (50%); sarcomatous component showed negative immunostaining for epithelial markers and for mesenchymal markers. The gene discussed is ESR1; the disease is neoplasm.